Shares of MediWound Gained 23% in First Day of Trading

Shares of MediWound MDWD jumped 23 percent to $17.27 in its first day of trading. Shares opened at 10:25 a.m. EDT on Thursday for $16 per share. The company raised $70 million after five million shares were priced at $14, the lower end of the initial range of $14-$16. Credit Suisse, BMO Capital, and Jefferies were the lead underwriters for the offering. MediWound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds and connective tissue disorders.